-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2025-522126-13-00
1
2025-08-29
Cold Induced Urticaria
-
2024-518914-18-00
4
2025-08-27
Moderate to Severely Active Ulcerative Colitis & Moderate to Severely
-
2024-518761-10-00
4
2025-08-25
Non-small Cell Lung Cancer
-
2024-514296-17-00
3
2025-08-05
Attention deficit hyperactivity disorder
-
2023-509630-19-00
5
2025-07-31
Esophageal Squamous Cell Carcinoma (ESCC)
-
2024-517383-28-00
5
2025-07-21
Acute haemorrhagic stroke
-
2023-506887-15-00
4
2025-07-14
Hepatocellular carcinoma
-
2024-516162-11-00
5
2025-07-14
Endocrine-Sensitive phosphatidylinositol 3-kinase (PIK3CA)-Mutated, Ho
-
2024-518378-14-00
5
2025-07-11
Leber congenital amaurosis (LCA)
-
2024-517647-31-00
4
2025-07-09
basal cell carcinoma
-
2024-513900-32-00
7
2025-07-03
Pancreatic Ductal Adenocarcinoma
-
2024-518771-66-00
9
2025-07-01
Hepatoblastoma, Rhabdomyosarcoma
-
2024-516355-41-00
4
2025-06-30
Chronic Inducible urticaria and Chronic Spontaneous Urticaria
-
2024-514539-67-00
4
2025-06-27
Systemic Sclerosis
-
2024-515646-16-00
4
2025-06-24
Recurrent, persistent, metastatic or locally advanced vulvar cancer
-
2025-520705-12-00
4
2025-06-24
Colitis Ulcerative
-
2024-516838-35-00
1
2025-06-23
Patients with relapsed/refractory Lymphoma or ALL aged ≥ 3 years
-
2024-519248-34-00
4
2025-06-17
Cervical Dystonia
-
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
-
2024-512302-25-00
5
2025-06-06
Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
-
2024-517422-25-00
5
2025-05-22
Metastatic Castration-resistant Prostate Cancer (mCRPC)
-
2024-515526-89-00
4
2025-05-16
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2024-519387-41-00
1
2025-05-07
tumor entities carrying the oncogenic driver fusion